These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 28810252

  • 1. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Uesaka K.
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [Abstract] [Full Text] [Related]

  • 2. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS, Shan QY, Xie WX, Chen B, Huang Y, Guo Y, Xie XY, Lu MD, Peng BG, Kuang M, Shen SL, Wang W.
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J.
    Cancer; 2013 Jan 01; 119(1):126-35. PubMed ID: 22736338
    [Abstract] [Full Text] [Related]

  • 5. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.
    Li T, Wang SK, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J.
    Liver Int; 2016 Feb 01; 36(2):284-92. PubMed ID: 26104132
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study.
    Hashimoto M, Tashiro H, Kobayashi T, Kuroda S, Hamaoka M, Ohdan H.
    Int J Surg; 2017 Mar 01; 39():206-213. PubMed ID: 28159713
    [Abstract] [Full Text] [Related]

  • 10. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    J Surg Oncol; 2014 Dec 01; 110(8):976-81. PubMed ID: 25171344
    [Abstract] [Full Text] [Related]

  • 11. Features and outcome after liver resection for non-B non-C hepatocellular carcinoma.
    Kaneda K, Kubo S, Tanaka H, Takemura S, Ohba K, Uenishi T, Kodai S, Shinkawa H, Urata Y, Sakae M, Yamamoto T, Suehiro S.
    Hepatogastroenterology; 2012 Sep 01; 59(118):1889-92. PubMed ID: 22819910
    [Abstract] [Full Text] [Related]

  • 12. Higher efficacy of antiviral therapy after major hepatectomy in patients with hepatitis B virus-related hepatocellular carcinoma of less than 3 cm.
    Zhang ZY, Zhou ZQ, Zhou GW.
    Eur J Gastroenterol Hepatol; 2014 Oct 01; 26(10):1116-24. PubMed ID: 25003747
    [Abstract] [Full Text] [Related]

  • 13. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
    Lee SB, Kim KM, An J, Lee D, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS.
    Liver Int; 2016 Sep 01; 36(9):1351-61. PubMed ID: 26913702
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After Hepatectomy.
    Takeishi K, Maeda T, Shirabe K, Tsujita E, Yamashita Y, Harimoto N, Itoh S, Ikegami T, Yoshizumi T, Maehara Y.
    Ann Surg Oncol; 2015 Dec 01; 22 Suppl 3():S1116-24. PubMed ID: 26159442
    [Abstract] [Full Text] [Related]

  • 15. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T, Hatano E, Sakurai T, Taura K, Okuno M, Kasai Y, Seo S, Yasuchika K, Mori A, Kaido T, Uemoto S.
    Ann Surg Oncol; 2015 Jul 01; 22(7):2226-34. PubMed ID: 25395147
    [Abstract] [Full Text] [Related]

  • 16. Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection.
    Zhang W, Tan Y, Jiang L, Yan L, Yang J, Li B, Wen T, Wu H, Wang W, Xu M.
    Int J Surg; 2017 Aug 01; 44():160-165. PubMed ID: 28629767
    [Abstract] [Full Text] [Related]

  • 17. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G, Lau WY, Zhou WP, Shen F, Pan ZY, Yuan SX, Wu MC.
    JAMA Surg; 2014 Jun 01; 149(6):519-27. PubMed ID: 24696192
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of hepatitis B core antibody-positive hepatocellular carcinoma.
    Nakai T, Koh K, Kawabe T, Shiraishi O, Okuno K, Yasutomi M.
    World J Surg; 2002 Jun 01; 26(6):700-3. PubMed ID: 12053222
    [Abstract] [Full Text] [Related]

  • 20. Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma.
    Nishikawa H, Arimoto A, Wakasa T, Kita R, Kimura T, Osaki Y.
    Oncol Rep; 2013 Jul 01; 30(1):91-8. PubMed ID: 23615658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.